INTERNATIONAL PATENT: INCYTE CORPORATION FILES APPLICATION FOR "RUXOLITINIB FOR TREATING HIDRADENITIS SUPPURATIVA (HS)"

GENEVA, June 12 -- INCYTE CORPORATION (1801 Augustine Cut-OffWilmington, Delaware 19803) filed a patent application (PCT/US2024/057617) for "RUXOLITINIB FOR TREATING HIDRADENITIS SUPPURATIVA (HS)" on Nov 27, 2024. With publication no. WO/2025/117642, the details related to the patent application was published on Jun 05, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CORNWELL, M. Celeste Ferreira (c/o Incyte Corporation1801 Augustine Cut-OffWilmington, 19803)

Abstract: This disclosure relates to methods for treating patients with hidradenitis suppurativa (HS) by administering a ruxolitini...